{
  "ticker": "NRIX",
  "company_name": "Nurix Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06691828",
      "title": "Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2024-11-01",
      "completion_date": "2024-12-05",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05131022",
      "title": "A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Waldenstrom Macroglobulinemia (WM), Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)",
      "start_date": "2022-04-13",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05107674",
      "title": "A Study of NX-1607 in Adults With Advanced Malignancies",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic or Unresectable Melanoma, Non-small Cell Lung Cancer (NSCLC), Metastatic Castration-resistant Prostate Cancer (mCRPC), Malignant Pleural Mesothelioma (MPM), Triple Negative Breast Cancer (TNBC), Metastatic Urothelial Carcinoma, Cervical Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Richter Transformation, Microsatellite Stable Colorectal Carcinoma",
      "start_date": "2021-09-29",
      "completion_date": "2028-02-28",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04830137",
      "title": "A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Follicular Lymphoma (FL), Diffuse Large B-cell Lymphoma (DLBCL), Primary Central Nervous System Lymphoma (PCNSL)",
      "start_date": "2021-05-05",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05107739",
      "title": "A Study of DeTIL-0255 in Adults With Advanced Malignancies",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Platinum-resistant Ovarian Cancer, Endometrial Cancer, Cervical Cancer",
      "start_date": "2021-12-22",
      "completion_date": "2023-05-09",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06593457",
      "title": "A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2024-08-20",
      "completion_date": "2024-11-14",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06717269",
      "title": "Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2024-11-30",
      "completion_date": "2025-12-31",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07221500",
      "title": "A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)",
      "start_date": "2025-10-15",
      "completion_date": "2030-10",
      "enrollment": 0,
      "sponsor": "Nurix Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 8,
    "by_phase": {
      "PHASE1": 7,
      "PHASE2": 1
    },
    "by_status": {
      "COMPLETED": 2,
      "RECRUITING": 5,
      "TERMINATED": 1
    },
    "active_trials": 5,
    "completed_trials": 2,
    "conditions": [
      "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)",
      "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Waldenstrom Macroglobulinemia (WM), Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)",
      "Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Follicular Lymphoma (FL), Diffuse Large B-cell Lymphoma (DLBCL), Primary Central Nervous System Lymphoma (PCNSL)",
      "Healthy Volunteer",
      "Healthy Volunteers",
      "Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic or Unresectable Melanoma, Non-small Cell Lung Cancer (NSCLC), Metastatic Castration-resistant Prostate Cancer (mCRPC), Malignant Pleural Mesothelioma (MPM), Triple Negative Breast Cancer (TNBC), Metastatic Urothelial Carcinoma, Cervical Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Richter Transformation, Microsatellite Stable Colorectal Carcinoma",
      "Platinum-resistant Ovarian Cancer, Endometrial Cancer, Cervical Cancer"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:19.684070",
    "search_query": "Nurix Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Nurix+Therapeutics,+Inc."
  }
}